Every individual has a unique endocannabinoid system that dictates how they respond to cannabis.
Endocanna currently sells a cannabis testing kit for US$199 which takes into account 57 genetic traits and has plans to produce similar kits for psychotropic drugs.
Earlier this year, Vancouver-based biotech company Entheon Biomedical Corp launched at-home test kits in both Canada and the U.S. through its wholly-owned subsidiary, HaluGen Life Sciences Inc.
Retailing for $89, the Psychedelics Genetic Test kit delivers a genetic profile and publishes personalized reports directly to consumers’ smartphones.
Users can learn about their potential sensitivity to classical psychedelics and serotonin response as well as genetic-based, mental health risk factors that can be affected by psychedelic use.
Toronto-based Lobo Genetics debuted its DNA testing kit in 2019. Costing $59, the test determines an individual’s genetic profile and potential response to THC and
Read full article on The Growth Op
